Navigation Links
SafeCode Drug Technologies Corporation Identifies the Technology Group to Commence and Develop the World's First Prototype for its Next Generation Application for Drug Safety Administration
Date:12/5/2012

JERUSALEM, December 5, 2012 /PRNewswire/ --

SafeCode Drug Technologies Corp. (OTCBB: SAFC)(the "Company"), a developer of patent-pending voice recognition technology that reduces the risks of errors during the administration of prescription medications, is pleased to announced it has identified and is commencing to develop the world's first prototype for its next generation application for Drug Safety Administration. The prototype development and the technology application is expected to be completed within 4-6 months and will be then demonstrated to worldwide major drug container manufacturers for possible adoption to ensure a new generation drug administration safety application.

The Company recently launched its new website which has also been optimized for accessibility and easy navigation on smartphones and tablets as well as laptops and home computers.  

In conjunction with the website unveiling, the Company has published a new video demonstrating the SafeCode voice-activation technology as a novel product candidate for the medical industry.  Investors are encouraged to view the video on the Company's website or on YouTube at http://www.youtube.com/watch?v=PEy9ygT6jaA.

Across the past month, the Company has been granted eligibility status by the Depository Trust Company and commenced trading on the OTC Bulletin Boards.

"We are dedicated to providing a high-quality product and transparency to our stakeholders. We are taking all necessary steps to meet these corporate goals and doing so in an expeditious manner," said Joel Klopfer, Chief Executive Officer at SafeCode Drug Technologies Corp.  "Accidental deaths resulting from administering incorrect medication represent a multi-billion-dollar area of unmet need.  We believe that we have a solution with our patent-pending voice-recognition technology that will benefit manufacturers, pharmacists and patients while building our corporate value.  This is an exciting time for our company and shareholders as we enter the commercialization phase.  The new website was important to us as it showcases the SafeCode solution while giving investors fast, user-friendly access to information on our company."

About SafeCode Drug Technologies

SafeCode Drug Technologies Corporation is the developer of a patent-pending voice recognition technology that provides an essential degree of security that can effectively prevent unauthorized administration of a prescription medication.  

Forward-Looking Statements

This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of SafeCode Drug Technologies Corp., and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated.  SafeCode Drug Technologies Corp. public filings may be viewed at http://www.sec.gov

Contact:
Joel Klopfer
Joel.Klofer1@gmail.com
+9722-5021322

 



'/>"/>
SOURCE Safecode Drug Technologies Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. SafeCode Drug Technologies Launches New Website With Product Video Demonstrating the Worlds Next Generation Application for Drug Safety Administration
2. SafeCode Drug Technologies Corp. in Negotiations With Manufacturers to Develop Prototype
3. SafeCode Drug Technologies Corp. Begins Trading on the Over-the-Counter Bulletin Board
4. OrthoAccel Technologies, Inc. Announces Appointment of New Chief Financial Officer
5. Innovative CA Tumor Marker Tests Technologies and Emerging Markets
6. BioSpecifics Technologies Corp. to Webcast, Live, at RetailInvestorConferences.com on December 6th
7. UV Flu Technologies Signs a Distribution Agreement with DPG Distribution
8. Alliqua Names David Johnson Executive Chairman of Aquamed Technologies and Member of Alliqua Board of Directors
9. DenMat Announces Signing a Purchase Agreement to Acquire PeriOptix Inc., Leading Provider of Magnification and Illumination Technologies
10. Abuse-Deterrent Medication Developer, Pisgah Laboratories, Achieves Top 5 Technologies Ranking
11. CLAAD Selects Egalet As Top Five Technologies To Reduce Prescription Drug Abuse Honoree
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb 23, 2017 Research and ... Devices Market Analysis & Trends - Industry Forecast to 2025" ... ... grow at a CAGR of around 9.2% over the next decade ... report analyzes the market estimates and forecasts for all the given ...
(Date:2/23/2017)... SAN DIEGO , Feb. 23, 2017 /PRNewswire/ ... MBVX), a clinical-stage oncology drug development company, announces ... Food and Drug Administration (FDA) authorizing the initiation ... a therapeutic treatment for pancreatic cancer. MVT-1075 ( ... antibody radioimmunotherapy (RIT). MabVax plans to initiate the ...
(Date:2/23/2017)... Orthopedic and cardiac devices will continue ... patterns lead to an increasing prevalence of musculoskeletal ... injuries, chronic back problems, heart valve replacement, and ... future of medical implants faces many uncertainties. ... more: - What types of medical implants ...
Breaking Medicine Technology:
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community ... will return to the La Gorce Country Club in Miami Beach to host ...
(Date:2/23/2017)... ... 2017 , ... Los Angeles-based weight loss surgeon Michael Feiz, M.D., F.AC.S. will ... to Hot,” which will begin airing on February 24, 2017. The show chronicles the ... 2012 reality television series, “Here Comes Honey Boo Boo.” The earlier series from TLC ...
(Date:2/23/2017)... IPSWICH, Mass. (PRWEB) , ... February 23, 2017 ... ... chosen as an approved content provider for the National Institute for Health ... care and social care-related organizations in the National Health Service (NHS) to search, ...
(Date:2/23/2017)... Denver, Colorado (PRWEB) , ... February 23, 2017 ... ... Dialog Magazine, an exciting, new, interactive publication where generations converge and explore the ... to expand their worldview, Dialog Magazine enables readers to gain understanding, increase empathy, ...
(Date:2/23/2017)... ... 23, 2017 , ... Healthcare Research & Analytics® (HRA®) in ... against cancer, has produced a seminal study that asked cancer survivors and their ... in a webinar, Defining Compassionate Care Through the Voices of Patients and Advocates ...
Breaking Medicine News(10 mins):